What is ISL (Intermediate Sleep Stage) in terms of polysomnography?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Sleep Latency (ISL) in Polysomnography

In polysomnography, ISL (Initial Sleep Latency) refers to the time it takes for a person to fall asleep after lights out, measured in minutes from the start of the recording to the first epoch of sleep. 1

Definition and Measurement

  • ISL is a critical parameter in sleep studies that quantifies the transition time from wakefulness to sleep onset 1
  • It is typically measured from lights out (beginning of the intended sleep period) to the first epoch scored as sleep (usually N1 sleep stage) 2
  • ISL is considered a CRITICAL outcome measure for evaluating sleep disorders, particularly circadian rhythm sleep-wake disorders 1

Clinical Significance

  • Prolonged ISL (>30 minutes) may indicate insomnia or delayed sleep phase disorder 2
  • Shortened ISL (<5 minutes) may suggest sleep deprivation or disorders of excessive sleepiness 2
  • ISL is used as a key diagnostic parameter in various sleep disorders, including:
    • Advanced Sleep-Wake Phase Disorder (ASWPD) 1
    • Delayed Sleep-Wake Phase Disorder (DSWPD) 1
    • Other circadian rhythm sleep-wake disorders 1

ISL Measurement Methods

  • Polysomnography (PSG): The gold standard for objective measurement of ISL 3, 4
  • Actigraphy: Provides an estimate of ISL through movement patterns 1
  • Subjective reports: Patient-reported time to fall asleep (less accurate but clinically relevant) 1

ISL in Treatment Evaluation

  • ISL is used to evaluate the effectiveness of various sleep disorder treatments:
    • Light therapy: In ASWPD, light therapy showed variable effects on ISL, with actigraphy showing a 1.85 minute increase and subjective reports showing a 41.02 minute increase 1
    • Melatonin treatment: In adults with DSWPD and depression, melatonin reduced ISL by 43.52 minutes as measured by PSG 1
    • In children with DSWPD, melatonin at 0.15 mg/kg reduced ISL by 43.80 minutes as measured by actigraphy 1

Interpretation Considerations

  • ISL values must be interpreted in the context of the measurement method (PSG vs. actigraphy vs. subjective) 1
  • The American Academy of Sleep Medicine has established standardized criteria for interpreting polysomnography data, including ISL 2
  • Inter-rater reliability for sleep staging affects ISL measurement, with substantial overall agreement (Cohen's kappa 0.76) 5

Common Pitfalls in ISL Interpretation

  • Different definitions and scoring criteria can result in significant variations in ISL values 2
  • First-night effect may artificially prolong ISL due to unfamiliar sleep environment 4
  • Medications (especially hypnotics, stimulants, or melatonin) can significantly alter ISL 6, 7
  • Technical factors such as sensor placement and recording quality can affect accurate ISL determination 8, 4

Clinical Applications

  • In treatment studies, ISL is used as an outcome measure to determine efficacy:
    • For DSWPD in adults without depression, melatonin treatment decreased ISL by 37.70 minutes 1
    • For children with DSWPD and psychiatric comorbidities, melatonin reduced ISL by 18.70 minutes 1
  • ISL can help differentiate between various sleep disorders when considered alongside other sleep parameters 9

Remember that ISL is just one component of a comprehensive sleep evaluation and should be interpreted alongside other polysomnographic parameters and clinical information 2, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Interpretation and Treatment of Polysomnography Data

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Polysomnography.

Handbook of clinical neurology, 2019

Research

Interpretation of the adult polysomnogram.

Otolaryngologic clinics of North America, 2007

Research

Interrater reliability of sleep stage scoring: a meta-analysis.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2022

Guideline

Melatonin Treatment for Sleep Disorders

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medications for Shift Work Sleep Disturbances

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.